Machine learning and conventional Cox regression to predict target-lesion revascularization after percutaneous coronary intervention - Scorecard - MDSpire

Machine learning and conventional Cox regression to predict target-lesion revascularization after percutaneous coronary intervention

  • By

  • Mona El-Faramawi

  • Marco Busco

  • Sören Möller

  • Lisette Okkels Jensen

  • Jens Flensted Lassen

  • July 1, 2026

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Machine Learning Techniques and Traditional Cox Regression for Predicting Target-Lesion Revascularization Following Percutaneous Coronary Intervention

At a Glance

CategoryDetail
ConditionTarget-Lesion Revascularization (TLR)
Key MechanismsMachine Learning (ML)-based Cox-LASSO and traditional Cox regression models for risk prediction.
Target PopulationPatients undergoing percutaneous coronary intervention (PCI) with stent implantation.
Care SettingCardiovascular procedures in a multi-center registry.

Key Highlights

  • Study included 24,360 patients with 34,149 de novo lesions treated with PCI.
  • Cox-LASSO showed minor improvement over traditional Cox regression for short-term TLR prediction.
  • Stepwise Cox regression had the best predictive performance for long-term TLR.
  • Risk factors for TLR were consistent across both Cox models and Cox-LASSO.
  • Models demonstrated intermediate predictive performance for risk stratification.

Guideline-Based Recommendations

Diagnosis

  • TLR defined as repeated PCI or CABG due to ISR or definite ST.

Management

  • Consider risk factors identified in predictive models for patient stratification.

Monitoring & Follow-up

  • Follow-up until death, December 31, 2022, or 5 years post-procedure.

Risks

  • Patients remain at risk for stent failure requiring reintervention.

Patient & Prescribing Data

All-comer patients with de novo lesions treated with PCI.

Incorporate predictive modeling for individualized treatment and follow-up.

Clinical Best Practices

  • Utilize both traditional and ML-based models for comprehensive risk assessment.
  • Ensure accurate data collection and follow-up in registry-based studies.

Related Resources & Content

Original Source(s)

Related Content